Abstract
Transcranial magnetic stimulation (TMS) is a safe and easy technique for stimulating neurons in the human central nervous system. Studies combining TMS with drugs in healthy subjects and patients have advanced our knowledge of how TMS activates brain circuits and led to new techniques for evaluating the function of specific systems. For example, TMS techniques can detect effects on axon membranes, glutamatergic and GABAergic synapses and the influence of catecholaminergic systems, as well as group differences due to genetic variations in the response to drugs. With this knowledge base, TMS can now be used to explore and compare the effects of drugs on brain systems and may also serve as a surrogate for behavioral responses in clinical trials.
Keywords: Transcranial magnetic stimulation (single pulse), transcranial magnetic stimulation (paired pulse), drug physiological effects, neurotransmitter agents, gaba, glutamate, monoamines, biogenic
Central Nervous System Agents in Medicinal Chemistry
Title: Transcranial Magnetic Stimulation in Clinical Pharmacology
Volume: 8 Issue: 4
Author(s): Dimitrios Kapogiannis and Eric M. Wassermann
Affiliation:
Keywords: Transcranial magnetic stimulation (single pulse), transcranial magnetic stimulation (paired pulse), drug physiological effects, neurotransmitter agents, gaba, glutamate, monoamines, biogenic
Abstract: Transcranial magnetic stimulation (TMS) is a safe and easy technique for stimulating neurons in the human central nervous system. Studies combining TMS with drugs in healthy subjects and patients have advanced our knowledge of how TMS activates brain circuits and led to new techniques for evaluating the function of specific systems. For example, TMS techniques can detect effects on axon membranes, glutamatergic and GABAergic synapses and the influence of catecholaminergic systems, as well as group differences due to genetic variations in the response to drugs. With this knowledge base, TMS can now be used to explore and compare the effects of drugs on brain systems and may also serve as a surrogate for behavioral responses in clinical trials.
Export Options
About this article
Cite this article as:
Kapogiannis Dimitrios and Wassermann M. Eric, Transcranial Magnetic Stimulation in Clinical Pharmacology, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (4) . https://dx.doi.org/10.2174/187152408786848076
DOI https://dx.doi.org/10.2174/187152408786848076 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Kinase C Modulates Aurora-kinase Inhibition Induced by CCT129202 in HMC-1560,816 Cell Line
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Is Renalase a Novel Player in Catecholaminergic Signaling? The Mystery of the Catalytic Activity of an Intriguing New Flavoenzyme
Current Pharmaceutical Design Editorial [Hot topic: Drug Targeting of Autoimmunity (Guest Editor: Manfred Kunz)]
Current Drug Discovery Technologies Literature Review: Use of Family History for Primary Paediatric Care as the Next Step Towards use of Genomics in Healthcare
Current Pediatric Reviews The Nociceptin/Orphanin FQ System as a Target for Treating Alcoholism
CNS & Neurological Disorders - Drug Targets Epigenetics and Adult Acute Myeloid Leukemia
Current Pharmacogenomics and Personalized Medicine CDK9: Therapeutic Perspective in HCC Therapy
Current Cancer Drug Targets Editorial [Hot Topic: Bringing Drugs Into the Injured Brain and Keeping Them There (Executive Guest Editors: Dirk M. Hermann and Pauline Patak)]
Current Pharmaceutical Design Midlife Modifiable Risk Factors for Dementia: A Systematic Review and Meta-analysis of 34 Prospective Cohort Studies
Current Alzheimer Research Meet Our Editorial Board Member
Current Neuropharmacology Is a "Mitochondrial Psychiatry" in the Future? A Review
Current Psychiatry Reviews Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editorial Board Member
Central Nervous System Agents in Medicinal Chemistry Homocysteine and Hyperhomocysteinaemia
Current Medicinal Chemistry The Relation between Stylometry and Neuroscience
Neuroscience and Biomedical Engineering (Discontinued) Reducing Anxiety of Pregnant Women with a History of Pregnancy Loss-A Randomize Clinical Trial
Current Women`s Health Reviews Visual and Associated Affective Processing of Face Information in Schizophrenia: A Selective Review
Current Psychiatry Reviews P2Y Receptor Activation Affects the Proliferation and Differentiation of Glial and Neuronal Cells: A Focus on Rat C6 Glioma Cells
Current Neuropharmacology Prolactin and Blood-Brain Barrier Permeability
Current Neurovascular Research Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design